Pure Bioscience, Inc. (PURE) Reports Q3 Loss of $0.04/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
Tweet
Share
E-mailGet Alerts PURE Hot Sheet
Price: $0.08 +14.29%
Financial Fact:
Total other income (expense): 768K
Today's EPS Names:
FNLC, LSBK, OVLY, More
Financial Fact:
Total other income (expense): 768K
Today's EPS Names:
FNLC, LSBK, OVLY, More
Join SI Premium – FREE
Pure Bioscience, Inc. (NASDAQ: PURE) reported Q3 EPS of ($0.04), versus ($0.05) reported last year. Revenue for the quarter came in at $207 thousand, versus $128 million reported last year.
For earnings history and earnings-related data on Pure Bioscience, Inc. (PURE) click here.
For earnings history and earnings-related data on Pure Bioscience, Inc. (PURE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Packaging Corp. (PKG) Tops Q3 EPS by 12c
- Nokia (NOK) Tops Q3 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
